Qiagen Beverly, Inc

C4 Therapeutics, Inc. is a biotechnology company based in Watertown, MA, specializing in targeted protein degradation. Their innovative approach, known as Targeted Protein Degradation (TPD), aims to develop a new generation of medicines for treating various diseases. Through their TORPEDO platform and focus on target selection, C4 Therapeutics is dedicated to transforming lives by degrading disease-causing proteins. With a strong leadership team, board of directors, and scientific advisory board, C4 Therapeutics is committed to advancing their pipeline of therapies, including CFT7455, CFT1946, and CFT8919. They also collaborate with industry partners such as Roche, Biogen, Betta Merck, and others to further their research and development efforts. At C4 Therapeutics, their values, people, and dedication to scientific progress drive their mission to revolutionize the treatment of diseases through targeted protein degradation.Generated from the website

Biomodels in Waltham offers a wide range of preclinical research services, specializing in contract services for biopharmaceutical companies. Their experienced team provides comprehensive preclinical CRO services to support the development of innovative therapies and drug candidates. Generated from their website's infomation

Aphios Corporation is a biopharmaceutical company that develops enhanced natural therapeutics for infectious diseases, cancer and quality-of-life medicines. The company s business strategy is to collaborate with multinational companies, such as Novartis, Bayer, Bristol-Myers Squibb, Eli Lilly and the Gillette Company, to develop enhanced therapeutic products. The resulting technology platforms and therapeutic products have garnered approximately 30 United States and international patents with several applications pending. Its product pipeline includes SuperCool Gingerol, a pill for aiding digestion; Zindol, a pill that mitigates nausea caused by chemotherapy and motion and morning sickness; Xantol, a pill to treat mild to moderate depression and anxiety; and LoTax, an intravenous medication for breast and ovarian cancer. Aphios is also developing antiviral therapeutics against HIV, influenza, smallpox and SARS. The company maintains its headquarters in Woburn, Mass.